Oxford Nanopore Technologies Ltd

Adam Lowe is VP of Commercial Operations at Oxford Nanopore Technologies.  Adam has held both commercial and R&D management roles in leading biotechnology companies.

Prior to joining Oxford Nanopore, Adam served as Director of Applied Markets at Illumina, and also built and led their product marketing/management team for next-generation sequencing.  Before his years at Illumina, Adam served as Director of Scientific Operations at Applied Biosystems (now Life Technologies).  Adam has worked in Business development at Agilent Technologies, co-founded a small biotechnology consulting firm, and was the first employee of Genetic Health, a healthcare startup focused on building on-line tools for risk assessment, management and research on the genetic basis of common disease.

Prior to joining the commercial world, Adam co-founded and ran (as Director of HIV Services) the primary care HIV medicine program at Chase Brexton Health Services, now the largest provider of HIV-related healthcare in the state of Maryland.

Adam is a graduate of the Johns Hopkins University in Baltimore, MD.